NCT02618629View on ClinicalTrials.gov

Mass Balance and Metabolism Study of 14C-Z-215

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

September 30, 2016

Conditions
Healthy Male Subjects
Interventions
DRUG

14C-Z-215

Single oral dose of 20mg Z-215 and 14C-Z-215 solution

Trial Locations (1)

Unknown

UK

Sponsors
All Listed Sponsors
lead

Zeria Pharmaceutical

INDUSTRY

NCT02618629 - Mass Balance and Metabolism Study of 14C-Z-215 | Biotech Hunter | Biotech Hunter